Holen Sie sich die Stockscreener-App
2.00
6.54%
-0.14
Schlusskurs vom Vortag:
$2.14
Offen:
$2.13
24-Stunden-Volumen:
81,455
Relative Volume:
0.85
Marktkapitalisierung:
$74.78M
Einnahmen:
$68.72M
Nettoeinkommen (Verlust:
$-24.01M
KGV:
-3.1766
EPS:
-0.6296
Netto-Cashflow:
$-24.95M
1W Leistung:
-14.45%
1M Leistung:
-13.79%
6M Leistung:
-9.91%
1J Leistung:
-30.07%
1-Tages-Spanne:
$1.91
$2.15
1-Wochen-Bereich:
$1.75
$2.38
52-Wochen-Spanne:
$1.21
$3.049
Edap Tms S A Adr Stock (EDAP) Company Profile
Firmenname
Edap Tms S A Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie EDAP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EDAP
Edap Tms S A Adr
|
2.00 | 80.02M | 68.72M | -24.01M | -24.95M | -0.6296 |
|
MCK
Mckesson Corporation
|
820.29 | 100.92B | 377.60B | 3.35B | 5.67B | 25.06 |
|
COR
Cencora Inc
|
340.93 | 65.49B | 316.65B | 1.91B | 1.14B | 9.7209 |
|
CAH
Cardinal Health Inc
|
190.22 | 45.33B | 234.31B | 1.61B | 1.85B | 6.6243 |
|
HSIC
Henry Schein Inc
|
64.64 | 7.66B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.60 | 889.76M | 2.22M | -5.63M | -1.68M | -0.24 |
Edap Tms S A Adr Stock (EDAP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-15 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-04-04 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-01 | Eingeleitet | Jefferies | Buy |
| 2021-04-28 | Eingeleitet | Piper Sandler | Overweight |
| 2020-04-15 | Eingeleitet | B. Riley FBR | Buy |
| 2014-07-28 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2014-06-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2013-03-05 | Eingeleitet | Northland Capital | Outperform |
| 2010-11-18 | Bestätigt | Morgan Joseph | Buy |
| 2009-08-20 | Bestätigt | Roth Capital | Hold |
| 2008-11-24 | Bestätigt | Roth Capital | Hold |
| 2008-03-26 | Bestätigt | Roth Capital | Hold |
| 2007-11-09 | Bestätigt | Roth Capital | Hold |
| 2007-03-16 | Bestätigt | Roth Capital | Hold |
| 2007-01-24 | Bestätigt | Roth Capital | Hold |
Alle ansehen
Edap Tms S A Adr Aktie (EDAP) Neueste Nachrichten
EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025 - GlobeNewswire Inc.
EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU - Sahm
Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation - Placera.se
Cash per share of EDAP TMS SA Sponsored ADR – GETTEX:EDA - TradingView
Will EDAP TMS S.A. Depositary Receipt stock outperform value stocksMarket Sentiment Report & Fast Entry High Yield Stock Tips - newser.com
EDAP TMS Focuses on Robotic HIFU Leadership in Prostate Cancer - MSN
France approves reimbursement for EDAP’s prostate cancer treatment - Investing.com
Market reaction to NDLS’s recent news2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Earnings call transcript: EDAP TMS Q2 2025 reports revenue growth, stock rises - Investing.com
EDAP TMS Secures EUR 36 Million Credit Facility for Growth - The Globe and Mail
EDAP secures €36 million credit facility from European Investment Bank By Investing.com - Investing.com
How hedge fund analytics apply to BP P.L.C. ADRhedged stock2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser
Will Suburban Propane Partners L.P. Limited Partnership benefit from macro trendsDay Trade & Low Risk Investment Opportunities - Newser
Tools to monitor EDAP TMS S.A. Depositary Receipt recovery probabilityFree Risk Adjusted Technical Entry Plan - Newser
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy - Investing.com
EDAP TMS at Jefferies Conference: Strategic Shift to HIFU Therapy By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 By Investing.com - Investing.com India
edap tms sa announces shareholder meeting for june 2025 - Investing.com
Improved Revenues Required Before EDAP TMS S.A. (NASDAQ:EDAP) Stock's 28% Jump Looks Justified - Sahm
H.C. Wainwright cuts EDAP stock price target to $14 By Investing.com - Investing.com South Africa
H.C. Wainwright cuts EDAP stock price target to $14 - Investing.com
Focal ablation shows promise in prostate cancer trial By Investing.com - Investing.com South Africa
Jefferies cuts EDAP TMS stock rating, slashes target to $2 - Investing.com
Piper Sandler cuts EDAP stock price target to $4.50, keeps rating - Investing.com
Earnings call transcript: EDAP TMS Q4 2024 sees revenue growth, stock surges - Investing.com
EDAP's Avenda Deal For AI-Assisted Cancer Care Likely To Drive Stock - Barchart.com
China Tumor Ablation Market Size & Outlook, 2024-2030 - Grand View Research
EDAP shares hold as analyst reiterates $19 target on growth - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
EDAP Forecast — Price Target — Prediction for 2026 - TradingView
Price to earnings ratio of EDAP TMS SA Sponsored ADR – NASDAQ:EDAP - TradingView
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga
Biotech & Pharma News, Stocks, FDA Decision, Clinical Trials - RTTNews
Technical Analysis of EDAP TMS SA Sponsored ADR (NASDAQ:EDAP) - TradingView
EDAP Stock Price and Chart — NASDAQ:EDAP - TradingView
Perkins Capital Raises Exposure in EDAP TMS - Insider Monkey
Edap Signs US$20 Mln Securities Purchase Accord To Fund US Clinical Studies Of Ablatherm-HIFU SystemQuick Facts - RTTNews
Finanzdaten der Edap Tms S A Adr-Aktie (EDAP)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):